DMH1 is a selective small-molecule BMP type I receptor (ALK2/3) kinase inhibitor. It affects the BMP signaling pathway by blocking BMP receptor activation, effectively inhibiting BMP-mediated osteogenesis, mineralization, and cancer cell proliferation, while promoting cardiomyocyte differentiation.
DMH1 Mechanism of Action: ALK2 Inhibition in Cancer Cell Research
DMH1 MOA：Targeting ALK2/BMP Signaling Pathway for Oncology